Download PDF
Klin Monbl Augenheilkd 2024; 241(04): 367-368
DOI: 10.1055/a-2215-8413
Der interessante Fall

Hypopyon and Vision Loss after Initially Complication-Free Cataract Surgery

Hypopyon und Sehverschlechterung nach komplikationsloser Kataraktoperation
Eda Arslan
1   Ophthalmology, Talacker Augen Zentrum Zürich (TAZZ), Zürich, Switzerland
,
Sandrine Zweifel
2   Ophthalmology, University Hospital Zürich, Zürich, Switzerland
,
Christoph Kniestedt
1   Ophthalmology, Talacker Augen Zentrum Zürich (TAZZ), Zürich, Switzerland
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

A 71-year-old man was referred for cataract surgery in the right eye, while the other eye was operated previously. The best-corrected visual acuity was 20/40 OD and 20/50 OS preoperatively at the baseline visit.



Publication History

Received: 08 October 2023

Accepted: 20 November 2023

Article published online:
23 April 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Seal DV, Barry P, Gettinby G. et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study. J Cataract Refract Surg 2006; 32: 396-406
    CrossrefPubMedGoogle Scholar
  • 2 Sridhar J, Kuriyan AE, Flynn jr. HW. et al. Endophthalmitis Caused by Serratia marcescens: Clinical features, Antibiotic Susceptibilities, and Treatment Outcomes. Retina 2015; 35: 1095-1100
    CrossrefPubMedGoogle Scholar
  • 3 Shah S, Bansal A, Rabinowitz M. et al. Endogenous Serratia marcescens endophthalmitis. Retin Cases Brief Rep 2014; 8: 7-9
    CrossrefPubMedGoogle Scholar
  • 4 Park CY, Lee JK, Chuck RS. Toxic anterior segment syndrome-an updated review. BMC Ophthalmol 2018; 18: 276
    CrossrefPubMedGoogle Scholar
  • 5 Yazgan S, Celik U, Ayar O. et al. The role of patientʼs systemic characteristics and plateletcrit in developing toxic anterior segment syndrome after uneventful phaco surgery: A case control study. Int Ophthalmol 2018; 38: 43-52
    PubMedGoogle Scholar
  • 6 Lockington D, Macdonald ECA, Young D. et al. Presence of free radicals in intracameral agents commonly used during cataract surgery. Br J Ophthalmol 2010; 94: 1674-1677
    CrossrefPubMedGoogle Scholar
  • 7 Théa Pharmaceuticals. Aprokam® by is the commercial name of an ophthalmic cefuroxime solution that is prophylactically used in phacoemulsification surgery. Accessed December 5, 2023 at: https://www.theapharma.ch/de/produkte/aprokam
    PubMedGoogle Scholar
  • 8 Gardner S, Barry P, Cordovés L. Toxic anterior segment syndrome and intracameral injection of cefuroxime axetil. Clin Ophthalmol 2015; 9: 1865-1867
    CrossrefPubMedGoogle Scholar
  • 9 Çakir B, Celik E, Aksoy NÖ. et al. Toxic anterior segment syndrome after uncomplicated cataract surgery possibly associated with intracameral use of cefuroxime. Clin Ophthalmol 2015; 9: 493-497
    CrossrefPubMedGoogle Scholar
  • 10 Sengillo JD, Chen Y, Garcia DP. et al. Postoperative endophthalmitis and toxic anterior segment syndrome prophylaxis. Ann Transl Med 2020; 8: 1548
    CrossrefPubMedGoogle Scholar